These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3444847)

  • 1. In vitro study of gastrointestinal diffusion system using disopyramide phosphate.
    Jedras Z; Janicki S
    Pharmazie; 1987 Dec; 42(12):842-4. PubMed ID: 3444847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium acetate gastrointestinal diffusion system. Part 1: Lithium acetate single-unit gastrointestinal diffusion system: preparation and release rate studies.
    Janicki S; Jedras Z
    Pharmazie; 1990 Jan; 45(1):45-7. PubMed ID: 2333312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium acetate gastrointestinal diffusion system. Part 2: Lithium acetate multi-unit gastrointestinal diffusion system: preparation and release rate studies.
    Jedras Z; Janicki S
    Pharmazie; 1990 Feb; 45(2):116-8. PubMed ID: 2339165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diltiazem multi-dose gastrointestinal diffusion system: preparation and release rate studies.
    Janicki S; Jedras Z
    Farmaco; 1989 May; 44(5):531-9. PubMed ID: 2789629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the gastrointestinal diffusion system (GDS): influence of acacia gum on mechanical and chemical properties in free cellulose acetate films.
    Mahieux P; Arnaud P; Chaumeil JC
    Pharmazie; 1992 Mar; 47(3):216-8. PubMed ID: 1615028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-coated tablets: a system for the controlled release of drugs.
    Källstrand G; Ekman B
    J Pharm Sci; 1983 Jul; 72(7):772-5. PubMed ID: 6886984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery.
    Strübing S; Metz H; Mäder K
    Eur J Pharm Biopharm; 2007 Apr; 66(1):113-9. PubMed ID: 17101269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of an in vitro method for prediction of human drug absorption I. Assessment of artificial membrane composition.
    Corti G; Maestrelli F; Cirri M; Furlanetto S; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):346-53. PubMed ID: 16359848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.
    Graffner C; Lagerström PO; Lundborg PN; Rönn OF
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):414-9. PubMed ID: 7298249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
    Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
    Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets.
    Garg A; Gupta M; Bhargava HN
    Eur J Pharm Biopharm; 2007 Nov; 67(3):725-31. PubMed ID: 17543513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
    Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
    Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.